KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	20,129	21,909	41,424	8,390	56,540	16,865
Short-Term Investments	-	-	-	2,000	6,000	2,000
Trading Asset Securities	10,252	15,786	6,889	52,690	-	-
Cash & Short-Term Investments	30,381	37,695	48,313	63,080	62,540	18,865
Cash Growth	-30.90%	-21.98%	-23.41%	0.86%	231.52%	80.64%
Accounts Receivable	15,651	14,947	14,049	15,331	16,756	15,458
Other Receivables	394.13	595.39	574.37	587.96	441.83	293.24
Receivables	16,045	15,542	14,624	16,419	17,598	15,751
Inventory	21,817	18,906	18,546	17,292	16,910	19,524
Prepaid Expenses	40.2	53.73	82.9	128.49	78.92	78.77
Other Current Assets	272.75	1,436	3,819	1,163	108.56	596.17
Total Current Assets	68,555	73,634	85,385	98,083	97,236	54,815
Property, Plant & Equipment	23,728	24,010	23,534	22,130	20,149	18,824
Long-Term Investments	5,530	5,836	4,003	3,383	4,375	399.27
Other Intangible Assets	3,613	3,962	3,497	2,865	2,973	2,467
Long-Term Deferred Tax Assets	-	-	-	563.51	669.94	775.2
Long-Term Deferred Charges	880.25	958.9	907.84	-	-	-
Other Long-Term Assets	24,537	3,987	3,977	3,923	3,998	4,040
Total Assets	126,843	112,387	121,303	130,947	129,401	81,320
Accounts Payable	7,954	7,400	7,284	7,098	6,721	8,690
Accrued Expenses	1,127	909.52	699	863.27	857.23	787.16
Short-Term Debt	24,007	4,000	18,080	50,774	7,000	10,000
Current Portion of Long-Term Debt	-	-	-	2,560	2,960	3,360
Current Portion of Leases	647.6	255.64	661.11	567.64	529.03	540.45
Current Income Taxes Payable	71.72	721.31	171.1	9.13	180.54	-
Other Current Liabilities	6,287	6,034	6,405	7,663	7,250	7,276
Total Current Liabilities	40,095	19,321	33,300	69,535	25,498	30,654
Long-Term Debt	12,000	18,542	15,926	-	43,121	-
Long-Term Leases	968.38	104.14	197.12	727.27	116.67	51.82
Long-Term Deferred Tax Liabilities	115.05	581.32	1,322	-	-	-
Other Long-Term Liabilities	118.3	0	0	-0	-0	-0
Total Liabilities	55,808	40,946	52,722	71,132	71,934	34,818
Common Stock	5,453	5,453	5,453	5,453	5,453	5,453
Additional Paid-In Capital	39,169	39,169	39,169	31,175	23,407	17,556
Retained Earnings	22,005	22,411	19,694	21,750	26,019	20,056
Comprehensive Income & Other	4,408	4,408	4,265	1,436	2,588	3,437
Shareholders' Equity	71,035	71,441	68,582	59,815	57,467	46,502
Total Liabilities & Equity	126,843	112,387	121,303	130,947	129,401	81,320
Total Debt	37,623	22,902	34,864	54,629	53,727	13,952
Net Cash (Debt)	-7,242	14,793	13,449	8,451	8,813	4,913
Net Cash Growth	-	10.00%	59.13%	-4.11%	79.40%	-
Net Cash Per Share	-599.20	1225.02	1284.46	777.88	801.30	503.84
Filing Date Shares Outstanding	10.91	10.91	10.91	10.91	10.91	10.91
Total Common Shares Outstanding	10.91	10.91	10.91	10.91	10.91	10.91
Working Capital	28,461	54,313	52,085	28,548	71,738	24,161
Book Value Per Share	6512.99	6550.23	6288.02	5484.28	5268.98	4263.64
Tangible Book Value	67,422	67,479	65,084	56,950	54,494	44,036
Tangible Book Value Per Share	6181.69	6186.97	5967.35	5221.60	4996.41	4037.48
Land	11,097	11,097	11,097	8,067	6,933	6,543
Buildings	15,819	15,819	15,571	15,033	15,094	14,100
Machinery	14,327	13,222	12,560	11,697	11,365	10,395
Construction In Progress	245.41	2,354	952.42	2,039	998.96	945.48

Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.